Literature DB >> 24458311

A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Molly Lubin1, Hubert Chen2, Brett Elicker1, Kirk D Jones1, Harold R Collard1, Joyce S Lee3.   

Abstract

BACKGROUND: Patients with interstitial lung disease (ILD) have poor health-related quality of life (HRQL). However, whether HRQL differs among different subtypes of ILD is unclear. The aim of this study was to determine whether HRQL was different among patients with idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis (CHP).
METHODS: We identified patients from an ongoing longitudinal cohort of patients with ILD. HRQL was assessed using the Short Form (SF)-36 medical outcomes form (version 2.0). Regression analysis was used to determine the association between clinical covariates and HRQL, primarily the physical component summary (PCS) and mental component summary (MCS) score. A multivariate regression model was created to identify potential covariates that could help explain the association between the ILD subtype and HRQL.
RESULTS: Patients with IPF (n = 102) were older, more likely to be men, and more likely to have smoked. Pulmonary function was similar between the groups. The patients with CHP (n = 69) had worse HRQL across all eight domains of the SF-36, as well as the PCS and MCS, compared with patients with IPF (P < .01-.09). This pattern remained after controlling for age and pulmonary function (P < .01-.02). Covariates explaining part of the relationship between disease subtype and PCS score included severity of dyspnea (P < .01) and fatigue (P < .01). Covariates explaining part of the relationship between disease subtype and MCS score included severity of dyspnea (P < .01), female sex (P = .02), and fatigue (P = .02).
CONCLUSIONS: HRQL is worse in CHP compared with IPF. HRQL differences between ILD subtypes are explained in part by differences in sex, dyspnea, and fatigue.

Entities:  

Mesh:

Year:  2014        PMID: 24458311      PMCID: PMC4042514          DOI: 10.1378/chest.13-1984

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 2.  Conceptualization and measurement of health-related quality of life: comments on an evolving field.

Authors:  John E Ware
Journal:  Arch Phys Med Rehabil       Date:  2003-04       Impact factor: 3.966

Review 3.  A review of health-related quality-of-life measures used in end-stage renal disease.

Authors:  E T Edgell; S J Coons; W B Carter; J D Kallich; D Mapes; T M Damush; R D Hays
Journal:  Clin Ther       Date:  1996 Sep-Oct       Impact factor: 3.393

4.  Impairment of quality of life in women with chronic obstructive pulmonary disease.

Authors:  Karlos Naberan; Angel Azpeitia; Jordi Cantoni; Marc Miravitlles
Journal:  Respir Med       Date:  2011-10-20       Impact factor: 3.415

5.  Specialist palliative care is more than drugs: a retrospective study of ILD patients.

Authors:  Sabrina Bajwah; Irene J Higginson; Joy R Ross; Athol U Wells; Surinder S Birring; Amit Patel; Julia Riley
Journal:  Lung       Date:  2012-01-05       Impact factor: 2.584

6.  Assessment of health-related quality of life in patients with interstitial lung disease.

Authors:  J A Chang; J R Curtis; D L Patrick; G Raghu
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

7.  Predictors of physical and mental health-related quality of life in patients with interstitial lung disease: a multifactorial analysis.

Authors:  Ana Cláudia Coelho; Marli Maria Knorst; Marcelo Basso Gazzana; Sérgio Saldanha Menna Barreto
Journal:  J Bras Pneumol       Date:  2010 Sep-Oct       Impact factor: 2.624

8.  Correlation between clinical parameters and health-related quality of life in women with COPD.

Authors:  Nilton Maciel Mangueira; Isabel Lucena Viega; Melissa de Almeida Melo Maciel Mangueira; Alcimar Nunes Pinheiro; Maria do Rosário da Silva Ramos Costa
Journal:  J Bras Pneumol       Date:  2009-03       Impact factor: 2.624

9.  Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?

Authors:  D A Lynch; J D Newell; P M Logan; T E King; N L Müller
Journal:  AJR Am J Roentgenol       Date:  1995-10       Impact factor: 3.959

10.  Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients.

Authors:  Jennifer A Cleland; Amanda J Lee; Susan Hall
Journal:  Fam Pract       Date:  2007-05-15       Impact factor: 2.267

View more
  18 in total

Review 1.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

2.  Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Jake G Natalini; Jeff J Swigris; Julie Morisset; Brett M Elicker; Kirk D Jones; Aryeh Fischer; Harold R Collard; Joyce S Lee
Journal:  Respir Med       Date:  2017-04-05       Impact factor: 3.415

Review 3.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

4.  Sleep disorders and health-related quality of life in patients with interstitial lung disease.

Authors:  Maria Mavroudi; Despoina Papakosta; Theodore Kontakiotis; Kaliopi Domvri; George Kalamaras; Vasiliki Zarogoulidou; Paul Zarogoulidis; Paschalina Latka; Haidong Huang; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Sleep Breath       Date:  2017-10-16       Impact factor: 2.816

5.  Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability.

Authors:  Atakan Topcu; H Hakan Mursaloglu; Yasemin Yalcinkaya; Sait Karakurt; Burcu Yagiz; Zeynep Alaca; Meryem Demir; Belkis Nihan Coskun; Ediz Dalkilic; Nevsun Inanc
Journal:  Clin Rheumatol       Date:  2021-04-03       Impact factor: 2.980

Review 6.  Imaging of Hypersensitivity Pneumonitis.

Authors:  Andrea L Magee; Steven M Montner; Aliya Husain; Ayodeji Adegunsoye; Rekha Vij; Jonathan H Chung
Journal:  Radiol Clin North Am       Date:  2016-08-11       Impact factor: 2.303

7.  Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Evans R Fernández Pérez; Mark Hamblin; Nina Patel; Mitchell Tener; Deepa Bhanot; Lacey Robinson; Sam Bullick; Lena Chen; Scully Hsu; Matthew Churpek; Donald Hedeker; Steven Montner; Jonathan H Chung; Aliya N Husain; Imre Noth; Mary E Strek; Rekha Vij
Journal:  ERJ Open Res       Date:  2017-08-17

Review 8.  Recent advances in managing idiopathic pulmonary fibrosis.

Authors:  Chiara Scelfo; Antonella Caminati; Sergio Harari
Journal:  F1000Res       Date:  2017-11-27

9.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

10.  Translation, cross-cultural adaptation, and measurement properties of the Brazilian-Portuguese version of the idiopathic pulmonary fibrosis-specific version of the Saint George's Respiratory Questionnaire (SGRQ-I) for patients with interstitial lung disease.

Authors:  Wagner Florentin Aguiar; Leandro Cruz Mantoani; Humberto Silva; Camile Ludovico Zamboti; Thatielle Garcia; Vinicius Cavalheri; Marcos Ribeiro; Janelle Yorke; Fabio Pitta; Carlos Augusto Camillo
Journal:  Braz J Phys Ther       Date:  2021-07-21       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.